source:
http://rxisk.org/sos-dopamine-antagonist-withdrawal-syndrome-caroles-story/SoS: Dopamine Antagonist Withdrawal Syndrome – Carole’s Story
The dopamine antagonists include the antipsychotic, anti-nausea, anti-itch and other groups of drugs.
The antipsychotics were the first of the modern psychotropic drugs to be linked to severe withdrawal, but even so few doctors today are aware that there can cause dependence and withdrawal or how bad the problems can be. These drugs are linked to one of the most severe examples of tolerance and dependence leading to a debilitating legacy effect – tardive dyskinesia. My first brush with the fact that dopamine antagonists can cause withdrawal came when Carole came to see me in 1996.
for the full article, go to
http://rxisk.org/sos-dopamine-antagonist-withdrawal-syndrome-caroles-story/Symptoms on stopping – antipsychoticsThe Table below gives some sense of the Symptoms on Stopping these drugs.
A few points to note. Some of these drugs like amisulpiride and sulpiride are available in Europe only and this is why they come up with zero values across the board. Some of the older drugs such as perphenazine shows as having lower withdrawal problems than Zyprexa (olanzapine) or Seroquel (quetiapine). It likely is better than either of these two newer drugs when it comes to withdrawal problems but the main reason they show up as worse is that the data here is based on FDA data from 2004 and perphenazine, trifluoperazine, chlorpromazine and older drugs were being used much less by then.
The Clozapine group of drugs that includes Zyprexa and Seroquel are noted as having some of the worse withdrawal problems. We are missing data on Clozapine at the moment but will add that data and others in due course. Lilly may have received marketing authorization to claim Zyrexa was useful in the maintenance treatment of Bipolar Disorders largely on the basis that it causes withdrawal problems and not stopping leads to an impression it is providing some help in maintaining wellbeing when in fact the drug is the problem that the drug is often treating.
Quite strikingly the relatively recently released Paliperidone (Invega) comes with significant dependence and withdrawal problems. The haloperidol group of drugs of which Paliperidone and Risperidone and Ziprasidone are included all have problems.
The missing data may give the impression that DAAWS is not as common as withdrawal from benzodiazepines, mood stabilizers or antidepressants but it is in fact every bit as bad. In addition to tardive dyskinesia, these drugs produce a well recognized tardive dysthymia and tardive akathisia along with the kinds of stress intolerance, temperature dysregulation and other problems that Carole had. See the RxISK Guide: Antipsychotics for Takers at
http://rxisk.org/antipsychotics-for-takers/again, refer to the source link.